8 results on '"Penco, Silvia"'
Search Results
2. MRI-guided vacuum-assisted breast biopsy: experience of a single tertiary referral cancer centre and prospects for the future
- Author
-
Penco, Silvia, Rotili, Anna, Pesapane, Filippo, Trentin, Chiara, Dominelli, Valeria, Faggian, Angela, Farina, Mariagiorgia, Marinucci, Irene, Bozzini, Anna, Pizzamiglio, Maria, Ierardi, Anna Maria, and Cassano, Enrico
- Published
- 2020
- Full Text
- View/download PDF
3. Disparities in Breast Cancer Diagnostics: How Radiologists Can Level the Inequalities.
- Author
-
Pesapane, Filippo, Tantrige, Priyan, Rotili, Anna, Nicosia, Luca, Penco, Silvia, Bozzini, Anna Carla, Raimondi, Sara, Corso, Giovanni, Grasso, Roberto, Pravettoni, Gabriella, Gandini, Sara, and Cassano, Enrico
- Subjects
BREAST tumor diagnosis ,OCCUPATIONAL roles ,HEALTH policy ,DIVERSITY & inclusion policies ,EQUALITY ,HEALTH services accessibility ,MINORITIES ,GENDER affirming care ,TELERADIOLOGY ,ARTIFICIAL intelligence ,RADIATION ,DIAGNOSTIC imaging ,LABOR supply ,CULTURAL competence ,HEALTH ,COMMUNICATION ,HEALTH equity ,PHYSICIANS ,ALGORITHMS - Abstract
Simple Summary: This paper delves into the persistent issue of unequal access to medical imaging, with a particular focus on breast cancer screening and its impact on marginalized communities and racial/ethnic minorities. Central to our discussion is the role of scientific mobility among radiologists in fostering healthcare policy changes that promote diversity and cultural competence. We propose various strategies to bridge this gap, including cultural education, sensitivity training, and diversifying the radiology workforce. These measures aim to improve communication with diverse patient groups and reduce healthcare disparities. Additionally, we explore the challenges and advantages of teleradiology as a means to extend medical imaging services to underserved areas. In the context of artificial intelligence, we emphasize the critical need to validate algorithms across diverse populations to ensure unbiased and equitable healthcare outcomes. Overall, this paper underscores the importance of international collaboration in addressing global access barriers, presenting it as a key to mitigating disparities in medical imaging access and contributing to the pursuit of equitable healthcare. Access to medical imaging is pivotal in healthcare, playing a crucial role in the prevention, diagnosis, and management of diseases. However, disparities persist in this scenario, disproportionately affecting marginalized communities, racial and ethnic minorities, and individuals facing linguistic or cultural barriers. This paper critically assesses methods to mitigate these disparities, with a focus on breast cancer screening. We underscore scientific mobility as a vital tool for radiologists to advocate for healthcare policy changes: it not only enhances diversity and cultural competence within the radiology community but also fosters international cooperation and knowledge exchange among healthcare institutions. Efforts to ensure cultural competency among radiologists are discussed, including ongoing cultural education, sensitivity training, and workforce diversification. These initiatives are key to improving patient communication and reducing healthcare disparities. This paper also highlights the crucial role of policy changes and legislation in promoting equal access to essential screening services like mammography. We explore the challenges and potential of teleradiology in improving access to medical imaging in remote and underserved areas. In the era of artificial intelligence, this paper emphasizes the necessity of validating its models across a spectrum of populations to prevent bias and achieve equitable healthcare outcomes. Finally, the importance of international collaboration is illustrated, showcasing its role in sharing insights and strategies to overcome global access barriers in medical imaging. Overall, this paper offers a comprehensive overview of the challenges related to disparities in medical imaging access and proposes actionable strategies to address these challenges, aiming for equitable healthcare delivery. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Future Directions in the Assessment of Axillary Lymph Nodes in Patients with Breast Cancer.
- Author
-
Pesapane, Filippo, Mariano, Luciano, Magnoni, Francesca, Rotili, Anna, Pupo, Davide, Nicosia, Luca, Bozzini, Anna Carla, Penco, Silvia, Latronico, Antuono, Pizzamiglio, Maria, Corso, Giovanni, and Cassano, Enrico
- Subjects
LYMPH nodes ,SENTINEL lymph nodes ,MACHINE learning ,SENTINEL lymph node biopsy ,AXILLARY lymph node dissection ,MICROMETASTASIS - Abstract
Background and Objectives: Breast cancer (BC) is a leading cause of morbidity and mortality worldwide, and accurate assessment of axillary lymph nodes (ALNs) is crucial for patient management and outcomes. We aim to summarize the current state of ALN assessment techniques in BC and provide insights into future directions. Materials and Methods: This review discusses various imaging techniques used for ALN evaluation, including ultrasound, computed tomography, magnetic resonance imaging, and positron emission tomography. It highlights advancements in these techniques and their potential to improve diagnostic accuracy. The review also examines landmark clinical trials that have influenced axillary management, such as the Z0011 trial and the IBCSG 23-01 trial. The role of artificial intelligence (AI), specifically deep learning algorithms, in improving ALN assessment is examined. Results: The review outlines the key findings of these trials, which demonstrated the feasibility of avoiding axillary lymph node dissection (ALND) in certain patient populations with low sentinel lymph node (SLN) burden. It also discusses ongoing trials, including the SOUND trial, which investigates the use of axillary ultrasound to identify patients who can safely avoid sentinel lymph node biopsy (SLNB). Furthermore, the potential of emerging techniques and the integration of AI in enhancing ALN assessment accuracy are presented. Conclusions: The review concludes that advancements in ALN assessment techniques have the potential to improve patient outcomes by reducing surgical complications while maintaining accurate disease staging. However, challenges such as standardization of imaging protocols and interpretation criteria need to be addressed. Future research should focus on large-scale clinical trials to validate emerging techniques and establish their efficacy and cost-effectiveness. Over-all, this review provides valuable insights into the current status and future directions of ALN assessment in BC, highlighting opportunities for improving patient care. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. An Unenhanced Breast MRI Protocol Based on Diffusion-Weighted Imaging: A Retrospective Single-Center Study on High-Risk Population for Breast Cancer.
- Author
-
Rotili, Anna, Pesapane, Filippo, Signorelli, Giulia, Penco, Silvia, Nicosia, Luca, Bozzini, Anna, Meneghetti, Lorenza, Zanzottera, Cristina, Mannucci, Sara, Bonanni, Bernardo, and Cassano, Enrico
- Subjects
DIFFUSION magnetic resonance imaging ,MAGNETIC resonance imaging ,MEDICAL screening ,BREAST cancer ,BRCA genes - Abstract
Purpose: This study aimed to investigate the use of contrast-free magnetic resonance imaging (MRI) as an innovative screening method for detecting breast cancer in high-risk asymptomatic women. Specifically, the researchers evaluated the diagnostic performance of diffusion-weighted imaging (DWI) in this population. Methods: MR images from asymptomatic women, carriers of a germline mutation in either the BRCA1 or BRCA2 gene, collected in a single center from January 2019 to December 2021 were retrospectively evaluated. A radiologist with experience in breast imaging (R1) and a radiology resident (R2) independently evaluated DWI/ADC maps and, in case of doubts, T2-WI. The standard of reference was the pathological diagnosis through biopsy or surgery, or ≥1 year of clinical and radiological follow-up. Diagnostic performances were calculated for both readers with a 95% confidence interval (CI). The agreement was assessed using Cohen's kappa (κ) statistics. Results: Out of 313 women, 145 women were included (49.5 ± 12 years), totaling 344 breast MRIs with DWI/ADC maps. The per-exam cancer prevalence was 11/344 (3.2%). The sensitivity was 8/11 (73%; 95% CI: 46–99%) for R1 and 7/11 (64%; 95% CI: 35–92%) for R2. The specificity was 301/333 (90%; 95% CI: 87–94%) for both readers. The diagnostic accuracy was 90% for both readers. R1 recalled 40/344 exams (11.6%) and R2 recalled 39/344 exams (11.3%). Inter-reader reproducibility between readers was in moderate agreement (κ = 0.43). Conclusions: In female carriers of a BRCA1/2 mutation, breast DWI supplemented with T2-WI allowed breast cancer detection with high sensitivity and specificity by a radiologist with extensive experience in breast imaging, which is comparable to other screening tests. The findings suggest that DWI and T2-WI have the potential to serve as a stand-alone method for unenhanced breast MRI screening in a selected population, opening up new perspectives for prospective trials. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Digital Twins in Radiology.
- Author
-
Pesapane, Filippo, Rotili, Anna, Penco, Silvia, Nicosia, Luca, and Cassano, Enrico
- Subjects
DIGITAL twins ,TELERADIOLOGY ,TECHNOLOGICAL innovations ,INDIVIDUALIZED medicine ,RADIOLOGY ,VIRTUAL reality - Abstract
A digital twin is a virtual model developed to accurately reflect a physical thing or a system. In radiology, a digital twin of a radiological device enables developers to test its characteristics, make alterations to the design or materials, and test the success or failure of the modifications in a virtual environment. Innovative technologies, such as AI and -omics sciences, may build virtual models for patients that are continuously adjustable based on live-tracked health/lifestyle parameters. Accordingly, healthcare could use digital twins to improve personalized medicine. Furthermore, the accumulation of digital twin models from real-world deployments will enable large cohorts of digital patients that may be used for virtual clinical trials and population studies. Through their further refinement, development, and application into clinical practice, digital twins could be crucial in the era of personalized medicine, revolutionizing how diseases are detected and managed. Although significant challenges remain in the development of digital twins, a structural modification to the current operating models is occurring, and radiologists can guide the introduction of such technology into healthcare. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. Recent Radiomics Advancements in Breast Cancer: Lessons and Pitfalls for the Next Future.
- Author
-
Pesapane, Filippo, Rotili, Anna, Maria Agazzi, Giorgio, Botta, Francesca, Raimondi, Sara, Penco, Silvia, Dominelli, Valeria, Cremonesi, Marta, Alicja Jereczek-Fossa, Barbara, Carrafiello, Gianpaolo, and Cassano, Enrico
- Subjects
RADIOMICS ,BREAST cancer ,MEDICAL personnel ,LYMPH node cancer ,PROGNOSIS ,NEOADJUVANT chemotherapy ,LYMPHATIC metastasis - Abstract
Radiomics is an emerging translational field of medicine based on the extraction of highdimensional data from radiological images, with the purpose to reach reliable models to be applied into clinical practice for the purposes of diagnosis, prognosis and evaluation of disease response to treatment. We aim to provide the basic information on radiomics to radiologists and clinicians who are focused on breast cancer care, encouraging cooperation with scientists to mine data for a better application in clinical practice. We investigate the workflow and clinical application of radiomics in breast cancer care, as well as the outlook and challenges based on recent studies. Currently, radiomics has the potential ability to distinguish between benign and malignant breast lesions, to predict breast cancer's molecular subtypes, the response to neoadjuvant chemotherapy and the lymph node metastases. Even though radiomics has been used in tumor diagnosis and prognosis, it is still in the research phase and some challenges need to be faced to obtain a clinical translation. In this review, we discuss the current limitations and promises of radiomics for improvement in further research. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
8. Inter-Reader Agreement of Diffusion-Weighted Magnetic Resonance Imaging for Breast Cancer Detection: A Multi-Reader Retrospective Study.
- Author
-
Pesapane, Filippo, Rotili, Anna, Penco, Silvia, Montesano, Marta, Agazzi, Giorgio Maria, Dominelli, Valeria, Trentin, Chiara, Pizzamiglio, Maria, Cassano, Enrico, and Pinker-Domenig, Katja
- Subjects
BREAST tumor diagnosis ,PATIENT aftercare ,STATISTICS ,RESEARCH evaluation ,MAGNETIC resonance imaging ,RETROSPECTIVE studies ,DESCRIPTIVE statistics ,NEEDLE biopsy ,BREAST tumors - Abstract
Simple Summary: The role of magnetic resonance imaging (MRI) in breast cancer has expanded in the last decade, and studies have demonstrated good sensitivity and specificity of diffusion-weighted imaging (DWI), a functional imaging technique reflecting water diffusion properties in tissues. However, clear results about the reproducibility of DWI are still missing. To utilize DWI as a reliable stand-alone technique for breast cancer detection, the inter-reader agreement of the measurement must be assessed. Accordingly, in this study, we assess the inter-reader reproducibility to retrospectively evaluate the agreement of breast cancer detection using DWI as a stand-alone technique. As our results show a good agreement only in expert readers, the assumption that a breast MRI based only on qualitative analysis of DWI, with fewer variables, may be easier for a non-expert reader to learn seems disproved, and future prospective studies should assess the right time for appropriate training for radiologists to investigate the potential role of DWI as a stand-alone method for un-enhanced breast MRI. Purpose: In order to evaluate the use of un-enhanced magnetic resonance imaging (MRI) for detecting breast cancer, we evaluated the accuracy and the agreement of diffusion-weighted imaging (DWI) through the inter-reader reproducibility between expert and non-expert readers. Material and Methods: Consecutive breast MRI performed in a single centre were retrospectively evaluated by four radiologists with different levels of experience. The per-breast standard of reference was the histological diagnosis from needle biopsy or surgical excision, or at least one-year negative follow-up on imaging. The agreement across readers (by inter-reader reproducibility) was examined for each breast examined using Cohen's and Fleiss' kappa (κ) statistics. The Wald test was used to test the difference in inter-reader agreement between expert and non-expert readers. Results: Of 1131 examinations, according to our inclusion and exclusion criteria, 382 women were included (49.5 ± 12 years old), 40 of them with unilateral mastectomy, totaling 724 breasts. Overall inter-reader reproducibility was substantial (κ = 0.74) for expert readers and poor (κ = 0.37) for non- expert readers. Pairwise agreement between expert readers and non-expert readers was moderate (κ = 0.60) and showed a statistically superior agreement of the expert readers over the non-expert readers (p = 0.003). Conclusions: DWI showed substantial inter-reader reproducibility among expert-level readers. Pairwise comparison showed superior agreement of the expert readers over the non-expert readers, with the expert readers having higher inter-reader reproducibility than the non-expert readers. These findings open new perspectives for prospective studies investigating the actual role of DWI as a stand-alone method for un-enhanced breast MRI. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.